Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$10M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| May 28 | JAZZ | Jazz Pharmaceuticals plc | MEXER | 3,415 | $138.08 | $471.5K | +0.3% | Open the original filing on SEC.gov |
| Aug 7, 2025 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 3,507 | — | — | +0.3% | Open the original filing on SEC.gov |
| May 12, 2025 | JAZZ | Jazz Pharmaceuticals plc | PBUY | 1,621 | $103.00 | $167K | +1.6% | Open the original filing on SEC.gov |
| May 9, 2025 | JAZZ | Jazz Pharmaceuticals plc | PBUY | 100 | $99.71 | $10K | +0.1% | Open the original filing on SEC.gov |
| May 9, 2025 | JAZZ | Jazz Pharmaceuticals plc | PBUY | 19,216 | $98.91 | $1.9M | +23.8% | Open the original filing on SEC.gov |
| May 9, 2025 | JAZZ | Jazz Pharmaceuticals plc | PBUY | 80,684 | $98.10 | $7.9M | — | Open the original filing on SEC.gov |